Aberrant high expression level of MORC2 is a common character in multiple cancers

Li, 2013, The MORC family: new epigenetic regulators of transcription and DNA damage response, Epigenetics, 8, 685, 10.4161/epi.24976 Moissiard, 2012, MORC family ATPases required for heterochromatin condensation and gene silencing, Science, 1448, 10.1126/science.1221472 Wang, 2010, Identification and expression analysis of a novel CW-type zinc finger protein MORC2 in cancer cells, Anat Rec (Hoboken), 293, 1002, 10.1002/ar.21119 Douse, 2018, Neuropathic MORC2 mutations perturb GHKL ATPase dimerization dynamics and epigenetic silencing by multiple structural mechanisms, Nat Commun, 9, 651, 10.1038/s41467-018-03045-x Tchasovnikarova, 2017, Hyperactivation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2, Nat Genet, 49, 1035, 10.1038/ng.3878 Schottmann, 2016, MORC2 mutation causes severe spinal muscular atrophy-phenotype, cerebellar atrophy, and diaphragmatic paralysis, Brain, 139, e70, 10.1093/brain/aww252 Shao, 2010, Involvement of histone deacetylation in MORC2-mediated down-regulation of carbonic anhydrase IX, Nucleic Acids Res, 38, 2813, 10.1093/nar/gkq006 Zhang, 2015, By recruiting HDAC1, MORC2 suppresses p21 Waf1/Cip1 in gastric cancer, Oncotarget, 6, 16461, 10.18632/oncotarget.3889 Wang, 2015, PAK1-mediated MORC2 phosphorylation promotes gastric tumorigenesis, Oncotarget, 6, 9877, 10.18632/oncotarget.3185 Sánchez-Solana, 2014, Cytosolic functions of MORC2 in lipogenesis and adipogenesis, Biochim Biophys Acta, 1843, 316, 10.1016/j.bbamcr.2013.11.012 Chen, 2011, Identification of prognostic genes for recurrent risk prediction in triple negative breast cancer patients in Taiwan, PLoS One, 10.1371/journal.pone.0028222 Tong, 1864, HSF1, in association with MORC2, downregulates ArgBP2 via the PRC2 family in gastric cancer cells, Biochim Biophys Acta, 2018, 1104 Liao, 2017, Chromatin remodeling protein MORC2 promotes breast cancer invasion and metastasis through a PRD domain–mediated interaction with CTNND1, Oncotarget, 8, 97941, 10.18632/oncotarget.18556 Hong, 2017, The emerging role of MORC family proteins in cancer development and bone homeostasis, J Cell Physiol, 232, 928, 10.1002/jcp.25665 Tong, 2015, Microchidia protein 2, MORC2, downregulates the cytoskeleton adapter protein, ArgBP2, via histone methylation in gastric cancer cells, Biochem Biophys Res Commun, 467, 821, 10.1016/j.bbrc.2015.10.059 Li, 2012, MORC2 signaling integrates phosphorylation-dependent, ATPase-coupled chromatin remodeling during the DNA damage response, Cell Rep, 1657, 10.1016/j.celrep.2012.11.018 Subramanian, 2005, Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles, Proc Natl Acad Sci U S A, 102, 15545, 10.1073/pnas.0506580102 Hanahan, 2011, Hallmarks of cancer: the next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013 Mounier, 2014, Lipogenesis in cancer progression (review), Int J Oncol, 45, 485, 10.3892/ijo.2014.2441 Calvisi, 2011, Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma, Gastroenterology, 140, 1071, 10.1053/j.gastro.2010.12.006 Lin, 2013, Acetylation stabilizes ATP-citrate lyase to promote lipid biosynthesis and tumor growth, Mol Cell, 51, 506, 10.1016/j.molcel.2013.07.002 King, 2014, Role of p-21–activated kinases in cancer progression, Int Rev Cell Mol Biol, 309, 347, 10.1016/B978-0-12-800255-1.00007-7 Eswaran, 2012, Molecular pathways: targeting p21-activated kinase 1 signaling in cancer—opportunities, challenges, and limitations, Clin Cancer Res, 18, 3743, 10.1158/1078-0432.CCR-11-1952 Weir, 2004, Somatic alterations in the human cancer genome, Cancer Cell, 433, 10.1016/j.ccr.2004.11.004